Insulin-like growth factor binding protein-3 mediates 1α,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1

Journal of Urology

Volumn 165, Issue 4, 2001, Pages 1319-1324

  Boyle, Bryan J ^a   Zhao, Xiao Yan ^a   Cohen, Pinchas ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin dependent kinases; Insulin like growth factor binding protein 3; Prostate; Prostatic neoplasms; Vitamin D

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCITRIOL; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P21; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0035093741     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)69892-6     Document Type: Article

References (26)

1. Vitamin D: Metabolism and action
2. Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential
3. Vitamin D: Anticancer and differentiation
4. Vitamin D and prostate cancer
5. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed
6. Actions of vitamin D3, analogs on human prostate cancer cell lines: Comparison with 1,25-dihydroxyvitamin D3
7. Vitamin D: A modulator of cell proliferation and differentiation
8. Monocytic differentiation of HL60 cells induced by potent analogs of vitamin D3 precedes the G1/G0 phase cell cycle block
9. 1,25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1
10. Calcitrol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2
11. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937
12. Growth inhibition of both MCF-7 and HS578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
13. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25 (OH) 2 D3 and its analog EB 1089
14. The IGF axis in the prostate
15. Insulin-like growth factors and their binding proteins: Biological actions
16. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
17. Insulin-like growth factor (IGF)- binding protein-3 induces apoptosis and mediates the effects of transforming growth factor beta1 on programmed cell death through a p53 and IGF-independent mechanism
18. Induction of the growth inhibitor IGF-binding protein 3 by p53
19. A study of the conditions and mechanism of the Diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid
20. Induction of androgen receptor by 1alpha, 25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells
21. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines
22. Cyclic adenosine 3′, 5′-monophosphate up-regulates 1,25-dihydroxyvitamin D3 receptor gene expression and enhances hormone action
23. A differential screen for ligand-regulated genes: Identification of HoxA as a target of vitamin D3 induction in myeloid leukemic cells
24. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor binding protein-3 action
25. Insulin-like growth factor binding protein 3 mediates retinoic acid and transforming growth factor beta 2-induced growth inhibition in human breast cancer cells
26. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells